Insider Sale by ROTHBLATT MARTINE A (Chairperson & CEO)
Trade Summary
6 days ago, ROTHBLATT MARTINE A, serving as Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $489.20 per share, for a total transaction value of $4,647,354.42. Following this transaction, ROTHBLATT MARTINE A now holds 324,443 shares of UTHR.
This sale represents a 2.84% decrease in ROTHBLATT MARTINE A's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Friday, September 4, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 8, 2026 at 4:31 PM ET, 4 days after the trade was made.
UNITED THERAPEUTICS Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$489.20
Quantity
9,500
Total Value
$4,647,354.42
Shares Owned
324,443
Trade Date
6 days ago
SEC Filing Date
at 4:31 PM ET
Filed 4 days after trade
Discussion